Guillem Porta, Vicente http://orcid.org/0000-0001-6073-6798
Camps, Carlos
Climent Durán, Miguel Ángel
Gallardo, Enrique
González del Alba, Aránzazu
Lázaro-Quintela, Martín
Méndez Vidal, María José
Pinto Marín, Álvaro
Puente, Javier
Antón-Rodríguez, Cristina
Caballero-Martínez, Fernando
Campos-Lucas, Francisco J.
Lugo, Ilse
Rogado, Álvaro
Durán, Ignacio
Funding for this research was provided by:
bristol-myers squibb
Article History
Received: 26 July 2021
Accepted: 24 August 2021
First Online: 5 September 2021
Change Date: 17 April 2022
Change Type: Update
Change Details: The original online version of this article was revised: to include the supplementary material.
Declarations
:
: María José Méndez Vidal has received honoraria for honoraria for speaker and advisory role from Astellas, Astra Zeneca, Janssen, MSD, Bayer, Pfizer, Eisai, Ipsen, Sanofi, Roche, and BMS. Miguel Ángel Climent Durán has received honoraria for speaker engagements or advisory roles from BMS, Astellas, Janssen, MSD, Sanofi, Bayer, Roche, Pfizer, EUNSA, Pierre Fabre, Novartis and Ipsen; and travel funding from Janssen, Astellas, Roche, Ipsen, and MSD. Enrique Gallardo has received honoraria for speaker engagements, advisory roles or continuous medical education from Sanofi, Janssen, Astellas, Bayer, Ipsen, Pfizer, Roche, Novartis, Eisai, EUSA Pharma, BMS, AstraZeneca, Merck, Rovi, Daiichi Sankyo, Techdow, Rovi, Leo Pharma, Menarini, and Boehringer-Ingelheim; consulting fees from Merck and EUSA Pharma; and grant support from Astellas, Janssen, Sanofi, Bayer, Ipsen, Ferrer, Pfizer, Roche, GSK, BMS. Aránzazu González del Alba has received honoraria for speaker engagements, advisory roles or continuous medical education from Astellas, Sanofi, Astra Zeneca, Eusa Pharma, Janssen, Bayer, Pfizer, Novartis, Eisai, Ipsen, Roche, BMS, and Pierre Fabre; research funding from Astellas; and consulting fees from Astellas, Janssen. Martín Lázaro-Quintela reports honoraria for speaker engagements, advisory roles or continuous medical education from Roche, Eisai, Astellas, Janssen, Astra-Zeneca, MSD, Bayer, Pfizer, Eusa, Ipsen, Takeda, Sanofi, Roche, BMS, Merck, and Boehringer-Ingelheim; and research funding from Roche, Pfizer, and Janssen. Álvaro Pinto has received honoraria for advisory roles or participation in clinical trials from Pfizer, Novartis, Ipsen, BMS, Janssen, Astellas, Sanofi, Bayer, Clovis, Pharmacyclics, Astra Zeneca, Eisai, Roche, MSD, Pierre Fabre and Merck; research funding from Pfizer and BMS; and travel funding from Janssen, Roche, Pfizer, BMS, and Ipsen. Javier Puente has received honoraria for speaker engagements, advisory roles, or continuous medical education from Astellas, Astra Zeneca, Janssen, MSD, Bayer, Pfizer, Eisai, Ipsen, Sanofi, Roche, BMS, Pierre Fabre, Merck; research funding from Astellas and Pfizer; and consulting fees from Astellas and Roche. The other authors have no conflicts of interest to declare.
: This study did not involve humans and did not require approval from an Ethical Committee.
: This study did not involve humans and informed consent was not necessary.